Navigation Links
Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
Date:8/27/2008

roviding the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and respiratory areas. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG (NYSE: NVS), which provides healthcare solutions that address the evolving needs of patients and societies. Focused on growth areas in healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, and consumer health products. Novartis is the only company with leading positions in these areas. In 2007, the Group's continuing operations (excluding divestments in 2007) achieved net sales of USD 38.1 billion and net income of USD 6.5 billion. Approximately USD 6.4 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 98,200 full-time associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

For more information

Additional information regarding G
'/>"/>

SOURCE Novartis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
2. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
3. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
4. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
5. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
6. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
7. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
8. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
9. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
10. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
11. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... , May 26, 2015  A simple blood ... Science Center to detect early Alzheimer,s disease is a ... Detailed standardized guidelines that are needed before ... been published in Alzheimer,s & Dementia . The ... an international working group that includes UNT Health Science ...
(Date:5/26/2015)... CA (PRWEB) May 26, 2015 ... the beginning of a long-term relationship with Veterinary ... behalf of its members to provide access to ... extremely pleased to count VGP as a dedicated ... arthritic dog patients nationwide. Concentrating and using stem ...
(Date:5/26/2015)... ANGELES , May 26, 2015 Mr. ... his family, thanks President Barack Obama and President ... during the time of loss of Dr. Rongxiang Xu ... humanitarian and a leader ahead of his time, Dr. Xu,s ... the community leave a legacy that will not be forgotten. ...
(Date:5/26/2015)... , May 26, 2015 Oramed ... a clinical-stage pharmaceutical company focused on the development of ... submitted the study protocol for the company,s Phase IIb ... U.S. Food and Drug Administration (FDA). The submission was ... application. The Phase IIb study of ORMD-0801 ...
Breaking Biology Technology:Guidelines bring UNT Health Science Center's blood test for Alzheimer's one step closer 2VetStem Biopharma & Veterinary Growth Partners Join Forces to Increase Member Veterinary Hospital Revenue Through Cutting Edge Medical Offering 2VetStem Biopharma & Veterinary Growth Partners Join Forces to Increase Member Veterinary Hospital Revenue Through Cutting Edge Medical Offering 3Dr. Rongxiang Xu, Beyond A Legend 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 3
... biobased industries could become a model for the rest of ... industry officials said at a leadership summit held Thursday at ... Wisconsin's forest and agricultural industry and its ties to the ... from the U.S. Department of Energy and the ...
... video-game developers gathered last week in Madison to explore ... education models, which speakers agreed early e-learning projects failed ... was sponsored by Games And Professional Practice ... Academic Distributed Learning (ADL) Co-Lab and a group ...
... suggest that scientists at UW-Madison or anywhere else in Wisconsin ... in the state has even announced plans to do so. ... process for cloning a human embryo for reproductive purposes is ... used in therapeutic cloning. The first step in both procedures ...
Cached Biology Technology:Wisconsins biobased industries could be world leader 2Wisconsins biobased industries could be world leader 3Gaming technologies alter classroom, textbook models 2Gaming technologies alter classroom, textbook models 3Gaming technologies alter classroom, textbook models 4Gaming technologies alter classroom, textbook models 5The Attack of the Clones: No, its not a summer movie 2The Attack of the Clones: No, its not a summer movie 3
(Date:5/11/2015)... Ohio , May 11, 2015  Through a well-rounded ... Ohio had a strong showing at AUVSI,s Unmanned ... These representatives of Ohio,s UAS industry ... and abroad from all points along the UAS ecosystem. ... Development Coalition,s (DDC) Vice President for Aerospace Rich Knoll ...
(Date:5/8/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), the ... of the executive management team will present at the following ... and Telecom Conference Date: May 18, 2015 Time: ... MA Cowen and Company Technology, Media ... Location: The New York Palace Hotel, New York, ...
(Date:5/5/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market, reminds investors and media that  Mr. David ... CARTES SECURE CONNEXIONS AMERICA 2015, held in Washington ... three-day conference is organized into a series of nine session ... Global Fraud: Where is the Trust in Cyberspace? and ...
Breaking Biology News(10 mins):Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Synaptics to Present at Upcoming Investor Conferences 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
... Institute Associate Scientist Thomas Brutnell is helping lead a ... attempting to solve one of the "grand challenges" in ... plants will grow and develop based on their particular ... found or planted. Solving this problem requires new computer ...
... recently diverged populations of a southern California songbird produce ... isolation that accompanies the origin of new bird species. ... in the preen oils of Dark-eyed Juncos is described ... so much we don,t know about the role of ...
... Montreal, March 23, 2010 Age and gender play a ... a new study on 20-to-64-year-olds. Published in the journal ... Universit de Montral and the Montreal Heart Institute in collaboration ... McGill University. "Our findings suggest that women who are ...
Cached Biology News:BTI's Brutnell leads part of NSF Computational Plant Biology Research System 2BTI's Brutnell leads part of NSF Computational Plant Biology Research System 3Could smell play a role in the origin of new bird species? 2Could smell play a role in the origin of new bird species? 3Men and women respond differently to stress 2
Mouse monoclonal [RIZ1723] to PRDM2/RIZ...
... OA-Hy cis- 9-Octadecenoyl-N-hydroxylamide Oleoyl-N-hydroxylamide ... PACKAGED UNDER INERT GAS. A potent inhibitor ... manner (K i = 1.7 μM). ... in EtOH or DMSO. Unstable in solution, ...
... with an early protein. ... hours post-infection exhibiting an intranuclear ... intensity between 6-24 hours. ... coarsely granular staining. No ...
Mouse monoclonal [1241] to Parainfluenza Virus type 2...
Biology Products: